Jaguar Health (JAGX) news
Recent news
Jaguar Health holder registers to resell up to 41M shares
Jaguar Health Inc. (NASDAQ: JAGX) announced that a shareholder has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) to resell up to 41 million shares of the company’s common stock [1]. The registration, which is part of a standard SEC process for secondary…
AInvest Wire · Jul 24, 2026Jaguar Health - registers resale of up to 40.8 mln shares of common stock by selling stockholder - SEC filing
AInvest Wire · Jul 16, 2026Jaguar Health - 2026 agreement set to expire on March 31, 2029 - SEC filing
Jaguar Health, Inc. (Nasdaq: JAGX) has been actively engaged with the Securities and Exchange Commission (SEC) through a series of filings in 2026, including multiple 8-K reports detailing unscheduled material events and corporate developments. These filings reflect the company’s ongoing efforts to…
AInvest Wire · Jul 14, 2026Jaguar Health - 2026 agreement includes minimum purchase commitment for crofelemer by Napo - SEC filing
AInvest Wire · Jul 14, 2026Jaguar Health - Napo and Alivus enter new manufacturing and supply agreement for crofelemer on July 9, 2026 - SEC filing
AInvest Wire · Jul 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.